Pharmaceutical care for hospitalized patients. Clinical and economic repercussion;Atención farmacéutica a pacientes hospitalizados. Repercusión clinica y económica

Atencion Farmaceutica

Volumn 4, Issue 6, 2002, Pages 384-396

  Gonzalez Fernandez Ma A ^a   Llorente Gutierrez J ^a   Ruano Encinar, M ^a   Jimenez Caballero E ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Clinical impact; Economic impact; Pharmaceutical care; Pharmaceutical interventions

Indexed keywords

ANTIINFECTIVE AGENT; ANTIULCER AGENT;

ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH PROGRAM; HOSPITAL CARE; MEDICAL SERVICE; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; SUSPENSION;

EID: 0036872262     PISSN: 11397357     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Catania HF, Yee WP, Catania PN. Four year's experience with a clinical intervention program; cost avoidance and impact of a clinical coordinator. Am J Hosp Pharm 1990; 47: 2701-5.
2. Taylor JT, Kathman MS. Documentation of cost saving from decentralized clinical pharmacy services at a community hospital. Am J Hosp Pharm 1991; 48: 1467-70.
3. Bjorson DC, Hiner WH, Potyk RP, Nelson BA, Lombardo FA, Morton TA, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J hosp Pharm 1993; 50: 1875-84.
4. Montazeri M, Cook DJ. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994; 22: 1044-8.
5. Baldinger SL, Chow MSS, Ganon RH, Kelly III ET. Cost Savings from having a clinical pharmacist work part-time in a medical intensive care unit. Am J Health-System Pharm 1997; 54: 2811-4.
6. Yee DK, Veal JH, Trinh B, Bauer S, Freeman CH. Involvement of HMO-based pharmacist in clinical rounds at contract hospitals. Am J Health-Syst Pharm 1997; 54: 670-3.
7. Mutnick AH, Stevera KJ, Peroutka JA, Sloan NE, Beltz EA, Sorenson MK. Cost savings and avoidance from clinical interventions. Am J Health-Syst Pharm 1997; 54: 392-6.
8. Bozek PS, Perdue BE, Bar-Din M, Weidle PJ. Effect of pharmacist interventions on medication use and cost in hospitalized patients with or without HIV infection. Am J Health-Syst Pharm 1998; 55: 1151-5.
9. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-70.
10. Institute of Medicine. To err is human: Building a safer health system. Washington, DC: National Academy Press; 1999.
11. Otero MJ, Domínguez-Gil A. Acontecimientos adversos por medicamentos: Una patología emergente. Farm Hosp 2000; 24: 258-66.
12. a época: 40-59.
13. American Society Hospital Pharmacists. ASHP statement on pharmaceutical care. Am J Hosp Pharm 1993; 50: 1720-3.
14. Robertson KE. Process of preventing or identifiying and resolvin porblesm in drug therapy. Am J Health Syst Phar 1996; 53: 639-50.
15. ASPH Guidelines on a standarized metod for pharmaceutical care. Am J Health Syst Pharm 1996: 53: 1713-6.
16. Farré Riba R. Clopes Estela A, Sola Esteban ML, Castro Cels I, Gámez Lechuga M, López Sánchez S, y cols. Intervenciones farmacéuticas (Parte I): Metodología y evalucón. Farm Hosp 2000; 24: 136-44.
17. Classen DC, Pestotnik SL, Evans RS, Lloyd J, Barke JP. Adverse Drug events in hospitalized patients. JAMA 1997; 277: 301-6.
18. Micromedex® Heathcare series. Vol 113, exp. 9/2002.
19. a de., 1988.
20. Catálogo de Especialidades Farmacéuticas 2002. Consejo general de Colegio oficiales de Farmacéuticos.
21. Comer J.B. Documenting pharmacists' Interventions. Am J Hosp Pharm. 1985; 42: 625-6.
22. Mutnick AH, Ziccarelli A, Derovin CG. Documenting pharmacists' services in a hospital pharmacy satellite. Am J Hosp Pharm. 1985; 42: 1988-9.
23. Huntress HD, Possid ente CJ, Harry DJ. Documenting pharmacists' interventiones on a hospital's mainframe computer system. Am J Hosp Pharm. 1990; 47: 2711-5.
24. Bearce WC, Willey GA, Foxd RL et al. Documentation of clinical interactions: quality of care issues and economic considerations in critical care pharmacy. Hosp Pharm. 1988; 23: 883-90.
25. Hatoum HT, Hotchinson RA, Witte KW, Newby GP. Evaluction of the contribution of clinical pharmacist: inpatient care and coste reduction. Drug Intell Clin Pharm. 1988; 22: 252-9.
26. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen L et al. The costs of adverse drug eventes in hospitalized patients. JAMA 1997; 277 (4): 307-311.
27. Izco Garcia N, Codina Jané C, Tusset Creus M, Manasanch Dalmau L, Gotsens Vila R, Ribas Sala J. Evaluación de la integración del farmacéutico en equipos de atención de unidades de hospitalización. Farm Hosp 2002; 26: 18-27.
28. Climente M. Resultados farmacoeconómicos del modelo de atención farmacéutica. Libro de Ponencias de XLVI Congreso de la Sociedad Española de Farmacia Hospitalaria. Valencia 2001: 279-95.
29. Clopes Estela A, Castro I, Sola Esteban ML, Farré Ribá R, Gámez Lechuga M, Ramos J. Intervenciones farmacéuticas (Parte II): validación de la metodología utilizada para medir el impacto. Farm Hosp 2000; 24: 215-20.
30. Campany D, Graus S, Manterde J, Salas E, Carmona A, Marín M y cols. Análisis de las intervencéones farmacéuticas realizadas a través de sistemas informáticos de dispensación en dosis unitaria Farm Hosp 1998; 22: 11-5.
31. Castilla Romera I, Martínez Hernández A, Martínez H, Suárez ML, Requena Caturla T. Atención farmacéutica a pacientes ingresados desde la unidad clínica. Farm Hosp 2000; 24: 27-31.
32. Cohen MR. If isn't documented, it wasn't done. Hosp Pharm 1989; 24: 180. Editorial.
33. aL, Aguilar Navarro T, Desongles Corrales T, Hathiramani Sánchez M, Rábano Al. Cambios en la terapéutica tras la intervención del farmacéutico. Farm Clin 1998; 15: 76-82.
34. aA., Gutiérrez Ramos R, Ruano Encinar M y cols. Atención Farmacéutica al paciente hospitalizado. Farm Hosp 2001; 25: 103. (Abtract).
35. American Society of Hospital Pharmacists'guidelines for implementing and obtaining compensation for clinical seryices by pharmacists. Am J Hosp Pharm 1985; 42: 1581-2.